Executive Summary
Boeing shares have rebounded 6.33% to $226.54 since the July 31 report, retracing the prior decline as the market digests record backlog levels, positive free cash flow generation, and Farnborough order momentum. The investment thesis remains anchored on operational execution and turnaround progress under CEO Kelly Ortberg, though the company continues to post core losses and trades within 10% of Morningstar's $246 fair value estimate.
Key Updates
Since the prior report dated July 31, 2026, Boeing's stock has advanced 6.33% from $213.05 to $226.54, more than reversing the previous session's 2.93% drop. The 5-day return stands at 7.11%, while the 1-month performance is effectively flat at +0.02%, indicating that the current rally has recovered ground lost earlier in the month. The move appears driven by continued absorption of Q2 earnings data, Farnborough order flow, and analyst commentary rather than by new company announcements post-July 31, as no additional disclosures have surfaced in the provided dataset.
Current Trend
Boeing is exhibiting a near-term bullish reversal. YTD performance is +4.34%, and the 6-month return of -2.84% shows that the stock remains in a broader consolidation phase. The current price of $226.54 sits above the July 30 level of $219.48 and well above the July 31 low of $213.05, establishing a higher-low structure on the daily timeframe. Resistance is now likely near the YTD highs, while support has moved up to the $213–$215 zone, underpinned by the post-earnings reaction low.
Investment Thesis
The thesis rests on Boeing's ability to convert record backlog into sustained free cash flow while stabilizing 737 MAX production and certifying delayed 777X and MAX-7/MAX-10 variants. Q2 2026 results showed operating cash flow of $1.4 billion and free cash flow of $0.6 billion, a sequential improvement that supports the path toward $1.5 billion in free cash flow for 2026 and over $10 billion by 2028. Global Services' 18.1% operating margin and $20.0 billion in cash and marketable securities provide liquidity buffers. However, the Commercial Airplanes segment remains loss-making with a (2.7)% margin, and Defense, Space & Security continues to absorb charges, including a $280 million Air Force One hit in Q2. Management has explicitly deprioritized new aircraft development until finances are repaired, focusing instead on execution.
Thesis Status
The turnaround thesis remains intact and is marginally strengthening on operational metrics, but it is not yet validated by sustained profitability. The Q2 delivery count of 171 commercial airplanes and 314 jets in the first half—Boeing's best H1 since 2018—supports the production recovery narrative. The record $715 billion backlog, including $597 billion in commercial orders, underpins multi-year revenue visibility. That said, the stock's 6.33% rally in three sessions compresses the margin of safety, particularly as Morningstar's fair value estimate of $246 implies limited upside from current levels.
Key Drivers
Primary catalysts include:
- Production ramp and certification milestones: Management targets increasing 737 output from 42 to 47 per month by late 2026, with 777X and 737 MAX-7/MAX-10 certification expected later this year. Source: Morningstar
- Order momentum: Boeing secured 173 aircraft orders at Farnborough, surpassing Airbus and marking its first major airshow win in four years, including 100 jets from SMBC Aviation Capital and 28 Boeing 787s for Riyadh Air. Source: Business Insider
- Defense segment headwinds: A $280 million charge on the Air Force One replacement program contributed to a $15 million operating loss in Defense, Space & Security. Source: Business Insider
- Capital allocation constraints: CEO Kelly Ortberg stated the company needs "a couple more years" to repair finances before launching a new commercial aircraft, signaling that capital will be directed toward stabilization rather than growth programs. Source: CNBC
- Quality improvements: Defect-related labor time on the 737 line has declined by nearly 20% and fuselage defects by 40%, supporting production reliability goals. Source: The New York Times
Technical Analysis
The price action has shifted from defensive to constructive. The +6.33% move since the last report reclaimed the $219.48 pivot from July 30 and closed the gap from the July 31 decline. YTD gains of +4.34% confirm that the broader trend is turning positive, though the 6-month return of -2.84% indicates resistance from longer-term holders. Immediate support is now $219–$220, followed by the psychological $213 level. Resistance is anticipated near $230–$235, with a secondary ceiling at Morningstar's $246 fair value estimate. Volume-driven follow-through will be necessary to confirm a breakout from the multi-month base.
Bull Case
- Record backlog of $715 billion provides unprecedented revenue visibility and insulates against near-term cyclicality. Source: PR Newswire
- Positive free cash flow of $0.6 billion in Q2 and a target of $1.5 billion for 2026 demonstrate that the cash generation turnaround is materializing ahead of the 2028 goal of $10 billion-plus. Source: Morningstar
- Farnborough order dominance (173 aircraft vs. Airbus's 154) signals renewed customer confidence and improves the mix of future deliveries. Source: Business Insider
- Global Services segment profitability (18.1% operating margin, $968 million operating profit) offers a stable earnings anchor while Commercial Airplanes recovers. Source: PR Newswire
- Operational metrics are improving measurably: 314 H1 deliveries represent the best first-half performance since 2018, and quality defect reductions support the production ramp to 47+ units per month. Source: The New York Times
Bear Case
- Core losses persist: Q2 core EPS was ($0.76) and the Commercial Airplanes margin was negative (2.7)%, indicating that the core business remains unprofitable at the operating level. Source: PR Newswire
- Defense segment margin pressure and program charges, including the $280 million Air Force One hit, continue to erode consolidated results and management credibility on fixed-price programs. Source: Business Insider
- Valuation compression: The stock trades within 10% of Morningstar's $246 fair value, limiting upside asymmetry and increasing downside sensitivity to execution missteps. Source: Morningstar
- CEO guidance explicitly rules out new product launches for "a couple more years," ceding potential narrowbody innovation leadership to Airbus and constraining long-term market share expansion. Source: CNBC
- Customer pushback on delays remains acute, evidenced by Emirates' refusal to accept the first 10 delayed 777X jets expected in 2027, underscoring ongoing delivery andexecution risk for the 777X program. Source: Business Insider